Most Popular

Benzodiazepines: our other prescription drug epidemic
CRISPR could end sickle cell disease, but signing up black patients for clinical trials will be a hard sell
How can we remedy the shortage of health providers?
Months after a sexual harassment scandal, OrbiMed’s banking another billion
Matching DNA to a diet doesn’t work: ‘We didn’t even come close,’ researcher says

FDA chides Collegium for obscuring risk info about its opioid painkiller
This gel loaded with drugs aims to hit cancer with a one-two punch
Pharmalittle: Greek parliament to probe Novartis bribery scandal; N.J. county goes after Purdue shareholders